secwatch.observer — SEC 8-K summary
======================================

Issuer:     Virpax Pharmaceuticals, Inc. (—)
CIK:        0001708331
Form:       8-K
Filed at:   2025-02-04T23:59:59+00:00
Accession:  0001731122-25-000163
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Jay Panis resigns from Virpax board and committees, effective Feb 3, 2025
--------------------------------------------------------------------------------

- Jay Panis resigned from the Board and all committees (Audit, Compensation, Nominating/Governance).
- Resignation due to compliance requirements with his current employer, not due to any disagreement with company.
- Company will begin process to identify a qualified independent director to fill the vacancy.
- No other director departures or executive officer changes reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708331/000173112225000163/0001731122-25-000163-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708331/000173112225000163/e6337_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-25-000163

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer